Get started
Author

Simge Acar

ORCID: 0000-0002-9757-5059
Observed ORCID: 0000-0002-9757-5059
OpenAlex ID: A5085297455
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
2020 · Juri Kiyokawa, Yoichiro Kawamura, et al. · Clinical Cancer Research · 111
A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses
2022 · Simge Acar, Edwin Nieblas-Bedolla, et al. · Pediatric Neurology · 9
PDF
Plexiform neurofibroma: shedding light on the investigational agents in clinical trials
2021 · Simge Acar, Amy E. Armstrong, et al. · Expert Opinion on Investigational Drugs · 9
Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review
2021 · Simge Acar, Sueda Sanli, et al. · International Urology and Nephrology · 7
Orthogonal targeting of KDM6A/B and HDACs mediates potent therapeutic effects in IDH1 -mutant glioma
2020 · Alisan Kayabolen, Ebru Yilmaz, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
PDF
Global protein changes associated with Chr8 gain in MPNST
2026 · Simge Acar · Synapse
Multi-omics integration of malignant peripheral nerve sheath tumors nominates therapies based on chromosome 8q status
2026 · Belinda B. Garana, Jiawan Wang, et al. · Research Square
PDF
Multi-omics integration of malignant peripheral nerve sheath tumors identifies potential targets based on chromosome 8q status
2026 · Belinda B. Garana, Jiawan Wang, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Tmod-26. Generation of a Chromosome 8 Gain;nf1-/- Hipsc-derived Schwann Cell Precursor Model
2024 · Gorkem Oztosun, Simge Acar, et al. · Neuro-Oncology
PDF
Gct-17. Exploring New Thresholds for Beta-hcg in Central Nervous System Germinoma
2024 · Malgorzata A Krawczyk, Simge Acar, et al. · Neuro-Oncology
Supplementary Table S2 from Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
2023 · Juri Kiyokawa, Yoichiro Kawamura, et al.
Supplementary Figures from Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
2023 · Juri Kiyokawa, Yoichiro Kawamura, et al.
Supplementary Table S1 from Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
2023 · Juri Kiyokawa, Yoichiro Kawamura, et al.
Supplementary Table S1 from Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
2023 · Juri Kiyokawa, Yoichiro Kawamura, et al.
Data from Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
2023 · Juri Kiyokawa, Yoichiro Kawamura, et al.
Data from Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
2023 · Juri Kiyokawa, Yoichiro Kawamura, et al.
Transition from locally developed, faculty-written (LFW) examinations to the National Board of Medical Examiners (NBME) subject examinations in clinical medical education
2022 · Atalay Demiray, Çınar Öztosun, et al. · SN Social Sciences
Ddre-03. Idh1-mutant Gbm Cells Are Highly Sensitive to Combination of Kdm6a/b and Hdac Inhibitors
2021 · Alişan Kayabölen, Gizem Nur Sahin, et al. · Neuro-Oncology Advances
Exth-10. Combination of Epigenetic Enzyme Inhibitors, Gsk-j4 and Belinostat, Reveals High Efficacy in Idh1 Mutant Gliomas
2020 · Alisan Kayabolen, Gizem Nur Sahin, et al. · Neuro-Oncology
PDF
Works count: 19
Citation count: 141
H-index: 5
I10-index: 1
Year
Topic
Type